Isolation of equine herpesvirus-1 mutants in the presence of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine: demonstration of resistance in vitro and in vivo.

The research article discusses the process of isolating specific mutants of equine herpesvirus-1 (EHV-1) in the presence of a compound known as HPMPA, establishing their resistance both in vitro, in lab settings, and in vivo, within living organisms.

Research Context and Methodology

• The researchers initiated this study based on the known effectiveness of a compound named (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA) in treating Equine Herpesvirus-1 (EHV-1) in a mouse model. This model is used for studying the equine variant of the disease, which affects horses.
• Their experiment aimed at isolating a series of EHV-1 mutants that could resist the compound. These mutants were isolated in both in-vitro (lab circumstance) and in-vivo (in a living organism) scenarios.

Findings and Conclusions

• From their observations, resistance was confirmed on a cellular level, meaning the mutant viruses were successful in surviving despite the introduction of the HPMPA compound.
• They proceeded to test one mutant model in mice. This mutant virus not only showed pathogenic behaviour, but it was also capable of infecting mice at a similar rate as the parental virus. The researchers were able to recover the infectious virus from the respiratory tissues and blood of the infected mice.
• Contrary to the in-vitro outcomes, the same mutant displayed a considerable level of resistance in the living organisms, thus in-vivo.
• The research concludes that the presence of resistance to the HPMPA compound, particularly in living organisms, demonstrates the virus-specific behaviour of the antiviral drug. This implies that the compound targets specific parts of the virus, providing useful insights for developing future antiviral therapies.

Implications of the Research

• The findings of this study have substantial implications for the development of antiviral drugs, specifically those seeking to treat EHV-1 in horses. Knowing that certain mutants can resist the compound can help inform the method and approach of future treatment strategies.
• The data also has wider implications in the field of virology. Observing the ability of the virus to mutate and resist an otherwise effective compound contributes to the broader understanding of how viruses behave and evolve.